In: PATENT NEWS
“If you are in Toronto, you probably don’t lack for the ability to get low cost or no cost assistance on IP issues because … universities in the area will have legal clinics,” said Turco, noting most clinics are tied to law schools. “[But] if you are in a more... Continue reading
In: PATENT NEWS
Greene’s Energy Group, LLC, held that the Patent Trial and Appeal Board could reconsider and cancel patent claims through inter partes review without violating Article III or the Seventh Amendment of the Constitution. The America Invents Act established inter partes reviews (IPRs) to allow any person …
In: PATENT NEWS
This report provides a factual overview of Non-Practicing Entity (NPE) related litigation and patent enforcement activities across the European Union (EU), including opposition actions filed before the European Patent Office (EPO). The findings are based on Dartsip’s database of IP case-law.
In: PATENT NEWS
IBM Files Patent For Proof-Of-Work Protocol Tailored To IoT Networks Cointelegraph Full coverage
In: PATENT NEWS
Merck Loses Bid to Collect Patent Infringement Damages from Gilead Insurance Journal Fed. Circ. Says Merck Atty’s Lies Doomed $200M Patent Win Law360 REFILE-US court upholds dismissal of $200 million Merck verdict against Gilead Reuters Full coverage
In: PATENT NEWS
Serono Fights Biogen’s Retrial Bid Over Nixed MS Drug Patent Law360 Full coverage
In: PATENT NEWS
Law360 (April 26, 2018, 7:46 PM EDT) — A New Jersey federal jury rightly found that a Biogen MA Inc. patent covering its multiple sclerosis treatment Avonex was invalid, because while the patent covered a new process, the treatment was decades old, EMD Serono Inc. told the court Wednesday.
In: PATENT NEWS
… invention and those found patent-eligible in Enfish, Thales Visionix Inc., Visual Memory and Finjan. These few cases are overshadowed by well over a hundred cases that upheld invalidation based on Alice. It is clear that the area of the law on software and business method patents is still evolving... Continue reading
In: PATENT NEWS
Rumors of the PTAB’s demise were greatly exaggerated, it turns out. In a 7-2 decision, the Supreme Court held on Tuesday that Inter Partes Reviews (IPRs) violate neither Article III nor the Seventh Amendment of the Constitution. Finding that the “grant of a patent is a matter involving public rights”... Continue reading
In: PATENT NEWS
Law360 (April 26, 2018, 4:30 PM EDT) — The Federal Circuit said Thursday that 01 Communique Laboratory can’t get a new trial after an Ohio jury cleared Citrix Systems of claims its software infringes Communique’s remote access computer patent, rejecting Communique’s arguments that Citrix tricked …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION